<qa>  What is the name of the type of carcinoma used as front line therapy?I. To establish whether the addition of OSI-774 Tarceva to the combination of paclitaxel and carboplatin encourages pathologic complete response pCR rates in patients with Stage III optimally cytoreduced stratum 1 and Stage III suboptimally cytoreduced or Stage IV stratum 2 ovarian, primary peritoneal or fallopian tube carcinomas when used as front line therapy. 